- Fellowship - Baylor College of Medicine (2010-2013), Hematology Oncology
- Residency - Baylor College of Medicine (2007-2010), Internal Medicine
- Medical School - UT Southwestern Medical School (2003-2007)
Siayareh Rambally, M.D.
- Internal Medicine - Hematology/Oncology
- Medical Treatment of Blood Disorders (Hematology)
Biography
Dr. Rambally specializes in the treatment of non-malignant blood disorders. Her research interests include sickle cell disease and bleeding disorders. She is actively involved in educating medical students, residents, and fellows.
Education & Training
Professional Associations & Affiliations
- American Society of Hematology (2010), Member
- Texas Medical Association (2013), Member
Honors & Awards
- D Magazine Best Doctor 2022
- Eugene P. Frenkel Teaching Award 2019-2020
- American Society of Hematology Trainee Research Award 2009
Books & Publications
-
Publications
-
Complete ADAMTS13 remission in a patient with refractory autoimmune-mediated thrombotic thrombocytopenic purpura after infliximab.
Bavli N, Lee N, Sarode R, Burstein E, Rambally S, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 2021 Jul 103213 -
Comparison of low fixed dose versus standard-dose rituximab to treat thrombotic thrombocytopenic purpura in the acute phase and preemptively during remission.
Reddy MS, Hofmann S, Shen YM, Nagalla S, Rambally S, Usmani A, Sarode R, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 2020 Jul 102885 -
Isolated Erythrocytosis Associated With 3 Novel Missense Mutations in the EGLN1 Gene.
Moore JA, Hubbi ME, Wang C, Wang Y, Luo W, Hofmann S, Rambally S, Journal of investigative medicine high impact case reports 2020 Jan-Dec 8 2324709620947256 -
Intravenous immunoglobulin as an adjunct therapy in persisting heparin-induced thrombocytopenia.
Park BD, Kumar M, Nagalla S, De Simone N, Aster RH, Padmanabhan A, Sarode R, Rambally S Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 2018 Aug 57 4 561-565 -
Resolution of acute hepatitis B-associated aplastic anaemia with antiviral therapy.
Hendren N, Moore J, Hofmann S, Rambally S BMJ case reports 2017 Oct 2017 -
Coagulation Testing in a Bleeding Patient.
Choi SH, Rambally S, Shen YM JAMA 2017 04 317 14 1479-1480 -
Fusobacterium nucleatum bacteremia presenting with portal vein thrombosis: an abdominal Lemierre syndrome?
Moore JA, Rambally S The American journal of medicine 2017 Feb -
Mixing Study for Evaluation of Abnormal Coagulation Testing.
Choi SH, Rambally S, Shen YM JAMA 2016 Nov 316 20 2146-2147 -
Ischemic stroke in a patient with moderate to severe inherited factor VII deficiency.
Reddy M, Tawfik B, Gavva C, Yates S, De Simone N, Hofmann SL, Rambally S, Sarode R Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 2016 Oct -
Transfusion management of factor V deficiency: three case reports and review of the literature.
Gavva C, Yates SG, Rambally S, Sarode R Transfusion 2016 Apr -
Treatment of refractory thrombotic thrombocytopenic purpura with N-acetylcysteine: a case report.
Li GW, Rambally S, Kamboj J, Reilly S, Moake JL, Udden MM, Mims MP Transfusion 2013 Oct -
Combining T-cell immunotherapy and anti-androgen therapy for prostate cancer.
Sanchez C, Chan R, Bajgain P, Rambally S, Palapattu G, Mims M, Rooney CM, Leen AM, Brenner MK, Vera JF Prostate cancer and prostatic diseases 2013 Jun 16 2 123-31, S1 -
Biochemical factors governing the steady-state estrone/estradiol ratios catalyzed by human 17beta-hydroxysteroid dehydrogenases types 1 and 2 in HEK-293 cells.
Sherbet DP, Guryev OL, Papari-Zareei M, Mizrachi D, Rambally S, Akbar S, Auchus RJ Endocrinology 2009 Sep 150 9 4154-62 -
Cofactors, redox state, and directional preferences of hydroxysteroid dehydrogenases.
Sherbet DP, Papari-Zareei M, Khan N, Sharma KK, Brandmaier A, Rambally S, Chattopadhyay A, Andersson S, Agarwal AK, Auchus RJ Molecular and cellular endocrinology 2007 Feb 265-266 83-8
-
Complete ADAMTS13 remission in a patient with refractory autoimmune-mediated thrombotic thrombocytopenic purpura after infliximab.
Research
- Von Willebrand disease
- Sickle cell disease
Clinical Focus
- Medical Treatment of Blood Disorders (Hematology)
Results: 1 Locations